{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:55:48Z","timestamp":1767840948078,"version":"3.49.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Radiolabeled fibroblast activation protein inhibitors (FAPIs) have been extensively used in different types of cancers, although not yet FDA approved. Normal patterns of FAPI biodistribution have been investigated, and it is known that FAPI is expressed in nonmalignant pathophysiological lesions, characterized by tissue remodeling such as atherosclerosis, arthritis, and scar\/fibrotic tissues. In this interesting image, we are presenting the accumulation of <jats:sup>68<\/jats:sup>Ga-FAPI in the gallbladder. This finding could be related to a normal distribution of the radiotracer as a physiologic finding. This is a potentially important finding as FAPI may be used as theragnostic agent in the future.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004955","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T22:00:11Z","timestamp":1700258411000},"page":"e40-e41","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["FAPI Uptake in Gallbladder Is It Normal Biodistribution?"],"prefix":"10.1097","volume":"49","author":[{"given":"Hossein","family":"Behnam-Manesh","sequence":"first","affiliation":[{"name":"Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abtin","family":"Doroudinia","sequence":"additional","affiliation":[{"name":"UT Southwestern Medical Center, Dallas, TX."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohadeseh","family":"Bayat","sequence":"additional","affiliation":[{"name":"Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Bakhshayesh Karam","sequence":"additional","affiliation":[{"name":"Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babak","family":"Salimi","sequence":"additional","affiliation":[{"name":"Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzieh","family":"Nejabat","sequence":"additional","affiliation":[{"name":"Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Payam","family":"Mehrian","sequence":"additional","affiliation":[{"name":"Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3390\/cancers11030316","article-title":"Tumor neovascularization and developments in therapeutics","volume":"11","year":"2019","journal-title":"Cancers (Basel)"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2537","article-title":"Tumor angiogenesis: molecular pathways and therapeutic targets","volume":"17","year":"2011","journal-title":"Nat Med"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.3390\/cancers13194946","article-title":"FAP and FAPI-PET\/CT in malignant and non-malignant diseases: a perfect symbiosis?","volume":"13","year":"2021","journal-title":"Cancers (Basel)"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","article-title":"A tumor-imaging method targeting cancer-associated fibroblasts","volume":"59","year":"2018","journal-title":"J Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3390\/cancers15030908","article-title":"PET\/CT with fibroblast activation protein inhibitors in breast cancer: diagnostic and theranostic application\u2014a literature review","volume":"15","year":"2023","journal-title":"Cancers (Basel)"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2967\/jnumed.119.236786","article-title":"Radiation dosimetry and biodistribution of 68Ga-FAPI-46 PET imaging in cancer patients","volume":"61","year":"2020","journal-title":"J Nucl Med"},{"key":"bib8-20250621","first-page":"9750080","article-title":"FAPI-04 uptake in healthy tissues of cancer patients in 68Ga-FAPI-04 PET\/CT imaging","volume":"2021","year":"2021","journal-title":"Contrast Media Mol Imaging"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/RLU.0000000000003621","article-title":"Increased 68Ga-FAPI uptake in chronic cholecystitis and degenerative osteophyte","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/RLU.0000000000004424","article-title":"Increased 68Ga-FAPI uptake in psammomatous meningioma in a patient with gallbladder cancer","volume":"48","year":"2023","journal-title":"Clin Nucl Med"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/RLU.0000000000004248","article-title":"Xanthogranulomatous cholecystitis masquerading as gallbladder carcinoma on 68Ga-FAPI-04 PET","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1097\/RLU.0000000000004641","article-title":"Role of 68Ga-FAPI PET\/CT in assessing hepatobiliary malignancies: a prospective pilot study","volume":"48","year":"2023","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:03:43Z","timestamp":1750532623000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004955","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,16]]}}}